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During the activation process of voltage-gated cation channels, the gating
charges in the voltage-sensor domain (VSD) translocate across a focused elec-
tric field spanned by a short distance where hydrophobic residues form an
occluded site in the gating pathway. In voltage-gated Kþ (Kv) channels, a
highly conserved phenylalanine in the middle of S2 is the core component
of the occluded site. This aromatic residue separates the extracellular and
intracellular hydrated crevices of the VSD and forms the charge transfer cen-
ter that catalyzes movement of the gating charges. Using a comprehensive
approach employing homology modeling, molecular docking, molecular dy-
namics (MD) simulation, mutagenesis and electrophysiology, we identifies
an activator-binding pocket in the gating pathway of KCNQ2 channel at the
occluded site where the electric field is highly focused. The opener-binding
pocket with a volume of about 170 A˚3 extends deeply inside the VSD and
can accommodate various activators. These results support the idea that the
gating charge pathways may be structurally diverse and can serve as direct
drug targets.
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Retigabine is the prototypical member of a novel class of anti-epileptic drugs
that act by potentiating neuronal KCNQ2/3 channels. Retigabine interacts
directly with the pore of KCNQ2/3 channels, requiring a conserved Trp, present
in both KCNQ2 and KCNQ3, but not KCNQ1. Application of 100 mM retiga-
bine to KCNQ3 channels causes a leftward 40 mV shift of the G-V curve that
can be strongly ameliorated with either Phe or Leu substitution of Trp 265, with
minor effects on channel gating. We have used nonsense suppression to subtly
alter the properties of this Trp residue (265) in homomeric KCNQ3[A315T]
channels to probe the chemical features of retigabine binding in more detail.
A tri-fluorinated Trp derivative (3,4,5-F-Trp), which reduces cation-pi binding
ability of this side chain caused a 20 mV left-shift in the gating properties of
KCNQ3, but these channels were still highly sensitive to retigabine, suggesting
that a cation-pi interaction is not essential for retigabine interactions with
KCNQ3. In contrast, Ind (an isosteric Trp derivative that lacks the indole nitro-
gen atom required for hydrogen bonding ability of Trp) substitution completely
abolished he effects of retigabine with minimal effects on KCNQ3 gating.
These observations demonstrate that retigabine binds KCNQ3 channels
through an energetically significant H-bond interaction via the indole nitrogen
of Trp 265. These findings stringently constrain models of retigabine binding to
KCNQ channels, and will guide the rational development of improved retiga-
bine derivatives.
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Kv7.4/7.5 Channels: Effects of ICA069673 and Ml213
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Kv7.4 and Kv7.5 voltage-activated potassium channels are proposed to
contribute to the maintenance of resting membrane voltage in smooth muscle
cells. We had previously provided evidence that Kv7.4 and Kv7.5 form pre-
dominantly heteromeric channels in vascular smooth muscle cells. Among
new activators of Kv7 channels, ICA069673 and ML213 were reported to
discriminate between Kv7.4 and Kv7.5 isoforms. Here we compare effects
of ICA069673 and ML213 on homomeric human Kv7.4, Kv7.5 and hetero-
meric Kv7.4/7.5 channels exogenously expressed in A7r5 vascular smooth
muscle cells. We found that in contradiction to previously published reports,
ML213 does not discriminate among Kv7.4 and Kv7.5 isoforms. ML213
significantly increased the maximum conductance of Kv7.4, Kv7.5 and het-
eromeric Kv7.4/7.5 channels. In each case, the increase in maximal conduc-
tance was accompanied by a negative shift of the activation curves by 23
mV, 47 mV and 32 mV; EC50: 1.5 mM, 3.4 mM and 3.2 mM for Kv7.4,Kv7.5 and heteromeric Kv7.4/7.5 channels, respectively. Current deactivation
rates decreased in a voltage dependent manner in the presence of the ML213
(10 mM) for all three channel combinations. In contrast to ML213,
ICA069673 was unable to enhance currents through Kv7.5 homomeric chan-
nels. However, both Kv7.4 and heteromeric Kv7.4/7.5 channels responded to
ICA069672 with a negative shift of activation curves by 57 mV (EC50 = 21
mM) and 66 mV (EC50 = 50 mM) respectively without increase in maximal
conductance. Current deactivation rates decreased in the presence of
ICA069673 with an opposite voltage dependence in comparison with deacti-
vation rates in the presence of ML213. Based on these results, neither ML213
nor ICA069673 are able to fully discriminate between homomeric Kv7.4,
Kv7.5 and heteromeric Kv7.4/7.5 channels exogenously expressed in A7r5
vascular smooth muscle cells.
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Human potassium channel KCNQ1 is expressed in several tissues including
inner ear, heart muscle, lung, intestine, and stomach, each requiring a unique
current profile for proper function. To tune its current output, KCNQ1 com-
plexes with several accessory proteins from the KCNE family. Each KCNE
family member modulates KCNQ1 differently: KCNE1 causes the channel
to delay opening and become more conductive in the open state, KCNE3
causes the channel to be constitutively open and more conductive, and
KCNE4 causes the channel to close. To extend previous efforts to characterize
the spectrum of KCNQ1 structure and modulation, we used a hybrid
experimental-computational approach to model the KCNQ1-KCNE3 com-
plex. Our strategy was to determine the NMR structure of KCNE3 alone in
lipid-mimicking bicelles, build a homology model of KCNQ1, generate in
vivo restraints using electrophysiology, and dock the structure of KCNE3
onto the homology model of KCNQ1 using electrophysiology-based restraints
to validate and refine the resulting models.The results from this method will
be presented.
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Polyunsaturated fatty acids (PUFAs) affect cardiac excitability by interacting
with ion channels. In this work we studied the effect of PUFAs on cardiac
Kv7.1 channels. We show that charged n-3 and n-6 PUFAs affect the voltage
dependence of Kv7.1 by shifting the conductance versus voltage (G(V))
curve towards hyperpolarized voltages. In contrast, uncharged methyl esters
of the PUFAs do not affect the voltage dependence of Kv7.1. The PUFA ef-
fect is pH dependent. This is likely because high pH deprotonates the PUFA,
making a larger fraction of PUFA molecules negatively charged and able to
affect Kv7.1 channel voltage dependence. The structural requirement of
PUFAs to induce Kv7.1 channel opening and the PUFA-induced effect on
channel voltage dependence were similar to those previously reported for
the Shaker K channel. This suggests a general modulatory mechanism in
which PUFAs electrostatically interact with the voltage-sensor domain of
the channel to induce channel opening. The putative PUFA interaction site
on Kv7.1, homologous to the previously reported PUFA interaction site on
the Shaker K channel, is close to the position of the auxiliary KCNE1 subunit
in the cardiac IKs channel. We therefore also investigated the impact of
KCNE1 on PUFA potency and found that the PUFA effect on Kv7.1 was
decreased by KCNE1 coexpression. By investigating the mechanism for
KCNE1-induced reduction of channel sensitivity to PUFAs, we found
that KCNE1 protonates the PUFA molecule making PUFAs uncharged
and ineffective. We furthermore explored the possibility to circumvent
KCNE1-effects on PUFA potency by testing PUFA analogues with different
properties. This study provides mechanistic information on how KCNE1 af-
fects pharmacological sensitivity of the Kv7.1 channel. This study may also
form the basis for the development of future Kv7.1 channel openers to be
used in the treatment of cardiac arrhythmia.
